vol. 2 no. 1
- Published online March 23, 2017.
Copyright & Usage
© European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
View Full Text
- Andrés Cervantes1⇑,
- María José Terol2
- 1 Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain
- 2 Department of Hematology, University of Valencia, Valencia, Spain
- Correspondence to Professor Andrés Cervantes, Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, 46010 Valencia, Spain;
↵AC and MJT contributed equally.